President Donald Trump said Sunday the U.S. had stockpiled 29 million pills of an anti-malaria drug he’s repeatedly pushed as a potential treatment for COVID-19, despite persistent warnings from the nation’s top infectious disease expert there is no “strong” evidence yet the medication could help rein in the ongoing pandemic.
“What do you have to lose?” Trump asked several times during a briefing at the White House, later saying: “I want them to try it, and it may work and it may not work. But if it doesn’t work, there is nothing lost by doing it. What I want is to save lives, but I don’t want it to be in a lab for a year and a half.”
He added: “I’m not acting as a doctor, I’m saying do what you want, but there are some good signs.”
The comments add to Trump’s growing persistence that hydroxychloroquine, an FDA-approved malaria prevention drug, could help save American lives as infection rates in the country topped 337,000. More than 9,600 people have died.
But the president’s hopeful claims about the drug go against the advice of many doctors, including Dr. Anthony Fauci, who leads the National Institute of Allergy and Infectious Diseases. Fauci has repeatedly and aggressively thrown water on the idea in recent days. He told CBS on Sunday we can’t “definitively say it works,” calling data thus far merely “suggestive.” In an interview with Fox News a day before, he said the country had to be “careful that we don’t make that majestic leap to assume that this is a knockout drug.” And during the press conference on Sunday, he said the country’s best hope right now to rein in the spread of the virus was simply “mitigation, mitigation, mitigation,” referring to social distancing measures and frequent hand-washing.
When a reporter attempted to ask Fauci about the president’s claims on Sunday, Trump refused to let him answer, saying the doctor had already done so “15 times.”
"I answered this 15 times. You don't have to answer." -- Trump prevents Dr Fauci from answering a question about hydroxychloroquine pic.twitter.com/8R1K1hDsaX— Aaron Rupar (@atrupar) April 6, 2020
Despite Fauci’s assertions, Trump and others in the White House continue to tout hydroxychloroquine as a potential balm to those infected with the virus. Axios reported Sunday that Fauci got into an argument with White House economic adviser Peter Navarro over claims the drug could be, as Trump’s referred to it, a “game-changer.”
“What, really, do we have to lose,” Trump continued on Sunday. “We have this medicine tested for many years, so it’s a very strong, powerful medicine but it doesn’t kill people. We don’t have time to go and say ‘gee, let’s take a couple years.’”
One small study on hydroxychloroquine out of China did find that a small number of patients that had mild illnesses due to COVID-19 were able to recover faster when administered the drug. The drug does have side effects, however, including headaches and nausea.
On Sunday, Trump once again said he looked forward to the country re-opening after cases of the coronavirus tapered off, although at the same time warning parts of the nation to prepare for a “peak” in the coming days.
“Right now things are looking really good and opening up with a bang will be a great thing,” the president said. “We have to open our country up. No country was designed for this.”
A HuffPost Guide To Coronavirus
- Stay up to date with our live blog as we cover the COVID-19 pandemic
- How long are asymptomatic carriers contagious?
- Why it might take weeks for people and businesses to get government relief
- How to feel less lonely during social distancing if you live alone
- I just got out of a COVID-19 ICU. Here’s how I made it through.
- How to make a no-sew coronavirus face mask
- What to do if you live with someone with COVID-19
- The HuffPost guide to working from home
- What coronavirus questions are on your mind right now? We want to help you find answers.
- Everyone deserves accurate information about COVID-19. Support journalism without a paywall — and keep it free for everyone — by becoming a HuffPost member today.
This article originally appeared on HuffPost.